EGFR and glioblastoma: One of the crucial steps in the pathogenesis of glioblastoma is the mutation of the EGFR receptor, which can occur concurrently with the formation of hybrid genes (e.g., EGFR/SEPT14 and EGFR/TACC) (OMIM 131550; OMIM 612140).